StemRIM
TSE:4599.T
Overview | Financials
Company Name | StemRIM |
Symbol | 4599.T |
Currency | JPY |
Price | 358 |
Market Cap | 22,025,262,282 |
Dividend Yield | 0% |
52-week-range | 321 - 735 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Masatsune Okajima |
Website | https://www.stemrim.com |
An error occurred while fetching data.
About StemRIM
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD